2-hydroxyemodin has been researched along with Cancer of Lung in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, X; Hu, B; Lin, H; Mao, J; Peng, Y; Wang, J; Wang, Y; Zhang, F; Zhang, T; Zheng, J | 1 |
1 other study(ies) available for 2-hydroxyemodin and Cancer of Lung
| Article | Year |
|---|---|
Overcoming Taxol-resistance in A549 cells: A comprehensive strategy of targeting P-gp transporter, AKT/ERK pathways, and cytochrome P450 enzyme CYP1B1 by 4-hydroxyemodin.
Topics: A549 Cells; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; Carcinoma, Non-Small-Cell Lung; Cell Line; Cell Movement; Cell Survival; Cytochrome P-450 CYP1B1; Drug Resistance, Neoplasm; Emodin; Humans; Lung Neoplasms; MAP Kinase Signaling System; Molecular Docking Simulation; Molecular Structure; Paclitaxel; Proteins; Proto-Oncogene Proteins c-akt | 2020 |